7,8-Dihydroxyflavone Ameliorates Scopolamine-Induced Alzheimer-Like Pathologic Dysfunction

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Rejuvenation Research

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/rej.2013.1519PMID 24325271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease.

  2014cited by this paper
• Acetyl-L-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation.

  2014cited by this paper
• β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

  2014cited by this paper
• BDNF-induced local protein synthesis and synaptic plasticity.

  2014cited by this paper
• Alzheimer's phenotypes induced by overexpression of human presenilin 2 mutant proteins stimulate significant changes in key factors of glucose metabolism.

  2013cited by this paper
• Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease

  2013cited by this paper
• Bis(9)-(-)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice.

  2013cited by this paper
• The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

  2013cited by this paper
• Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice.

  2013cited by this paper
• Angelica keiskei ameliorates scopolamine-induced memory impairments in mice.

  2013cited by this paper
• 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.

  2013cited by this paper
• 7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice.

  2013cited by this paper
• Neuroprotective Role of a Novel Copper Chelator against Aβ 42 Induced Neurotoxicity

  2013cited by this paper
• Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.

  2013cited by this paper
• Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain

  2012cited by this paper
• Melatonin Attenuates Scopolamine-Induced Memory/Synaptic Disorder by Rescuing EPACs/miR-124/Egr1 Pathway

  2012influential reference
• Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study.

  2012cited by this paper
• Folate and Alzheimer: when time matters

  2012cited by this paper
• 7,8‐dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats

  2012cited by this paper
• Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice.

  2012cited by this paper
• Attenuation of scopolamine-induced cognitive dysfunction by obovatol

  2012cited by this paper
• Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation.

  2012cited by this paper
• A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease

  2011cited by this paper
• A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

  2010cited by this paper
• Role of neurotrophic factors in depression.

  2007cited by this paper
• The redox chemistry of the Alzheimer's disease amyloid β peptide

  2007cited by this paper
• The redox chemistry of the Alzheimer's disease amyloid beta peptide.

  2007cited by this paper
• Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation

  2003cited by this paper
• Phosphatidylinositol 3‐kinase

  1994cited by this paper
• New Drug Development --- Alzheimer' Disease

  1994cited by this paper

• Increase in BACE1 Phosphorylation in the Rat Hippocampus and Phytosphingosine in Plasma After Chronic Administration of Scopolamine

  2026cites this paper
• Neuroprotective effects of astaxanthin in a scopolamine-induced rat model of Alzheimer’s disease through antioxidant/anti-inflammatory pathways and opioid/benzodiazepine receptors: attenuation of Nrf2, NF-κB, and interconnected pathways

  2025cites this paper
• Enhancement of response learning in male rats with intrastriatal infusions of a BDNF -TrkB agonist, 7,8-dihydroxyflavone.

  2025cites this paper
• UPLC-ESI–MS/MS phytochemical profile, in vitro, in vivo, and in silico anti-Alzheimer’s activity assessment of Pithecellobium dulce (Roxb.) Benth. leaves

  2025cites this paper
• Potential neuroprotective benefits of plant-based fermented foods in Alzheimer's disease: an update on preclinical evidence.

  2024cites this paper
• Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease

  2024cites this paper
• Enhancement of response learning in male rats with intrastriatal infusions of a BDNF - TrkB agonist, 7,8-dihydroxyflavone

  2024cites this paper
• Mitigating cognitive deficits with teriflunomide: unraveling PI3K-modulated behavioral outcomes in mice

  2024cites this paper
• Effects of extracts and manna of Echinops cephalotes on impaired cognitive function induced by scopolamine in mice

  2024influential citation
• Thymol in Trachyspermum ammi seed extract exhibits neuroprotection, learning, and memory enhancement in scopolamine‐induced Alzheimer's disease mouse model

  2023influential citation
• Minocycline alleviated scopolamine-induced amnesia by regulating antioxidant and cholinergic function

  2023cites this paper
• THE INFLUENCE OF MESENCHYMAL STEM CELLS ON THE DYNAMICS OF REGULATOR OF ENDOTHELIAL PROLIFERATION EXPRESSIONS IN THE BRAIN STRUCTURES OF RATS WITH EXPERIMENTAL ALZHEIMER-TYPE DEMENTIA

  2023cites this paper
• Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

  2023cites this paper
• Enhanced neuronal activity by suffruticosol A extracted from Paeonia lactiflora via partly BDNF signaling in scopolamine-induced memory-impaired mice

  2023cites this paper
• Folicitin abrogates scopolamine induced oxidative stress, hyperlipidemia mediated neuronal synapse and memory dysfunction in mice

  2023cites this paper
• Recovery of neurosurgical high-frequency electroporation injury in the canine brain can be accelerated by 7,8-dihydroxyflavone.

  2023cites this paper
• Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model

  2022cites this paper
• Opioid tolerance and opioid-induced hyperalgesia: Is TrkB modulation a potential pharmacological solution?

  2022cites this paper
• Pharmacological evaluation of newly synthesized benzimidazole derivative for anti-Alzheimer potential

  2022cites this paper
• EXPERMENTAL MODELS FOR MEMORY IMPAIRMENT

  2021cites this paper
• Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders.

  2021cites this paper
• 7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development

  2021cites this paper
• The TrkB agonist 7,8-dihydroxyflavone improves sensory-motor performance and reduces lipid peroxidation in old mice.

  2020cites this paper
• Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease

  2020cites this paper
• Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer’s Disease

  2020cites this paper
• Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders.

  2020cites this paper
• Effects of 7,8-Dihydroxyflavone on Lipid Isoprenoid and Rho Protein Levels in Brains of Aged C57BL/6 Mice

  2020cites this paper
• The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity.

  2019cites this paper
• Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model

  2019cites this paper
• A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model.

  2019cites this paper
• The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease

  2018cites this paper
• Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound

  2017cites this paper
• The Protective Role of Selenium on Scopolamine-Induced Memory Impairment, Oxidative Stress, and Apoptosis in Aged Rats: The Involvement of TRPM2 and TRPV1 Channels

  2017cites this paper
• Mitochondrial involvement in memory impairment induced by scopolamine in rats

  2017cites this paper
• Selenium attenuates apoptosis, inflammation and oxidative stress in the blood and brain of aged rats with scopolamine-induced dementia

  2017cites this paper
• TrkB activation by 7, 8‐dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease

  2016cites this paper
• 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders

  2016cites this paper
• Sesame Oil Modulates Scopolamine-Induced Alzheimer-Like Pathological Dysfunction in Rats

  2016cites this paper
• Scopolamine-based pharmacological MRI model for testing procognitive agents

  2016cites this paper
• Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.

  2016cites this paper
• The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia

  2016cites this paper
• Toxin-Induced Experimental Models of Learning and Memory Impairment

  2016cites this paper
• Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease

  2016cites this paper
• 7,8-Dihydroxyflavone Ameliorates Cognitive Impairment by Inhibiting Expression of Tau Pathology in ApoE-Knockout Mice

  2016cites this paper
• Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases

  2016cites this paper
• No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.

  2015cites this paper
• Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological Aberrations

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

  2014cites this paper
• Animal models of dementia and cognitive dysfunction.

  2014cites this paper
• Animal Models of Cognitive Impairment in Neurodegenerative and Organic Disorders

  year unknowncites this paper